SharePoint
Aide
IRSN, Institut de radioprotection et de sûreté nucléaire

Search our site :

ok

Contact us :

ok
En Fr

Enhancing Nuclear Safety


Research

Publications

Application of in vitro dissolution tests to different uranium compounds and comparison with in vivo data

E. Ansoborlo, R.A. Guilmette, M.D. Hoover, V. Chazel, P. Houpert and M.H. Hengé-Napoli
Radiat. Prot. Dosim. 1998, 79(1-4), pp 33-37
WORKSHOP ON INTAKES OF RADIONUCLIDES: Occupational and Public Exposure - Proceedings of a Workshop held in Avignon, France. September 15-18 1997

Document type > *Article de revue, *Congrès/colloque

Keywords > radiotoxicology, contamination, uranium

Research Unit > LEAR_(Laboratory for applied studies on radiotoxicology)

Authors > HOUPERT Pascale

Publication Date > 01/01/1998

Summary

The most recent ICRP respiratory tract dosimetry model (Publication 66) proposes default values for the absorption of radionuclides into blood, defined as Type F, M or S, but recommends whenever possible the use of specific absorption parameters obtained from in vitro or in vivo experiments. Although in vivo data are preferred, in vitro dissolution is generally easier to determine and can be considered to provide intermediate values between default and in vivo absorption parameters. This study had therefore three objectives. The first was to compare in vitro dissolution test systems developed at IRSN and LRRI. The second was to use both test systems with several uranium compounds present at different stages of the uranium nuclear fuel cycle. The third objective was to compare these in vitro data with those obtained from in vivo experiments performed on rats intratracheally instilled with the same uranium compounds. In vitro and in vivo data sets were then used to calculate and compare specific dose coefficients.

Close

Send to a friend

The information you provide in this page are single use only and will not be saved.
* Required fields

Recipient's email:*  

Sign with your name:* 

Type your email address:*   

Add a message :

Do you want to receive a copy of this email?

Send

Cancel

Close

WP_IMPRIMER_TITLE

WP_IMPRIMER_MESSAGE

Back

Ok